相关实验视频

Updated: Jun 8, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.7K

PD-1和PD-L1抑制剂之间的免疫相关毒性差异:在患有晚期癌症的患者中进行的一项回顾性队列研究

Cecilia Olsson Ladjevardi1,2, Marcus Skribek3,4, Anthoula Koliadi1,2

  • 1Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.

Cancer immunology, immunotherapy : CII
|November 7, 2024
PubMed
概括

与晚期癌症患者的PD-L1抑制剂相比,与免疫相关的不良事件 (IRAE) 与PD-1抑制剂相比较少见. 这项现实研究支持临床试验结果,表明PD-L1抑制剂具有更有利的毒性概况.

关键词:
晚期的癌症 晚期的癌症群组研究是一项群组研究.与免疫相关的不良事件.这是一种PD-1抑制剂.这是一种PD-L1抑制剂.

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

246
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.5K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480